Veru Inc. (NASDAQ: VERU) Q4 2020 earnings call dated Dec. 09, 2020. Corporate Participants: Samuel Fisch -- Director, Investor Relations Mitchell Steiner -- Chairman, President, and
Veru Inc. (VERU) Q4 2020 Earnings Call Transcript
Categories
Biotechnology
Avid Bioservices, Inc. (CDMO) Q2 2021 Earnings Call Transcript
Avid Bioservices, Inc. (NASDAQ: CDMO) Q2 2021 earnings call dated Dec. 02, 2020 Corporate Participants: Tim Brons -- Investor Relations Nicholas Green -- President and Chief
Is it time to book profits from Moderna?
Moderna (NASDAQ: MRNA) stock has soared a staggering 679% since the beginning of this year. If you did identify the potential of
Alexion’s long-term prospects remain intact amid continued focus on rare diseases
Alexion Pharmaceuticals, Inc. (NASDAQ: ALXN) has stood out in the crowded pharmaceuticals marketplace by developing effective treatments for certain rare health conditions. The
China Biologic Products Holdings, Inc. (CBPO) Q3 2020 Earnings Call Transcript
China Biologic Products Holdings, Inc. (NASDAQ: CBPO) Q3 2020 earnings call dated Nov. 25, 2020. Corporate Participants: Philip Lisio -- Investor Relations, The Foote
Is it the right time to invest in Agilent Technologies (A)?
Agilent Technologies, Inc. (NYSE: A) ended fiscal 2020 on a positive note, bettering its performance consistently after experiencing a slowdown in the
Palatin Technologies, Inc. (PTN) Q1 2021 Earnings Call Transcript
Palatin Technologies, Inc. (AMEX: PTN) Q1 2021 earnings call dated Nov. 17, 2020 Corporate Participants: Carl Spana -- President and Chief Executive Officer Stephen
COVID-19 vaccine: Pfizer (PFE) and Moderna (MRNA) are ahead in the race, where are the others?
Pfizer Inc. (NYSE: PFE) and Moderna Inc. (NASDAQ: MRNA) have made significant progress in their efforts to develop a vaccine against the
Moderna (MRNA) gains as COVID-19 vaccine candidate shows over 94% efficacy
Shares of Moderna Inc. (NASDAQ: MRNA) were up over 8% in morning trade on Monday as the company reported positive results from
Bio-Path Holdings, Inc. (BPTH) Q3 2020 Earnings Call Transcript
Bio-Path Holdings, Inc. (NASDAQ: BPTH) Q3 2020 earnings call dated Nov. 13, 2020 Corporate Participants: Will O'Connor -- Stern Investor Relations Peter Nielsen -- President, Chief
Biocept Inc (BIOC) Q3 2020 Earnings Call
Biocept Inc (NASDAQ: BIOC) Q3 2020 earnings call dated Nov. 12, 2020 Corporate Participants: Bruce Voss -- Investor Relations Michael W. Nall -- President and Chief
PDL BioPharma, Inc. (PDLI) Q3 2020 Earnings Call Transcript
PDL BioPharma, Inc. (NASDAQ: PDLI) Q3 2020 earnings call dated Nov. 11, 2020 Corporate Participants: Jody Cain -- Senior Vice President, LHA Dominique Monnet -- President
Biogen (BIIB) might need to revisit pipeline after Alzheimer’s drug setback
The controversy surrounding biotechnology firm Biogen's (NASDAQ: BIIB) Alzheimer's drug Aducanumab took a positive turn last week after the FDA issued a
Immunogen Inc (IMGN) Q3 2020 Earnings Call Transcript
Immunogen Inc (NASDAQ: IMGN) Q3 2020 earnings call dated Nov. 06, 2020 Corporate Participants: Courtney O'Konek -- Senior Director of Corporate Communications and Investor
CVS Health Corp. (CVS) Q3 2020 Earnings Call Transcript
CVS Health Corp. (NYSE: CVS) Q3 2020 earnings call dated Nov. 06, 2020 Corporate Participants: Valerie C Haertel -- Senior Vice President, Investor Relations
Amarin Corporation plc (AMRN) Q3 2020 Earnings Call Transcript
Amarin Corporation plc (NASDAQ: AMRN) Q3 2020 earnings call dated Nov. 05, 2020 Corporate Participants: Elisabeth Schwartz -- Senior Director, Investor Relations John Thero -- President
McKesson Corp. (MCK) Q2 2021 Earnings Call Transcript
McKesson Corp. (NYSE: MCK) Q2 2021 earnings call dated Nov. 03, 2020 Corporate Participants: Holly Weiss -- Senior Vice President, Investor Relations Brian S.
AbbVie (ABBV) to focus more on pipeline as recovery gathers pace
AbbVie, Inc. (NYSE: ABBV) has been recovering steadily from the virus-related slowdown and latest statistics show that the company's performance has improved
Moderna Inc. (MRNA) Q3 2020 Earnings Call Transcript
Moderna Inc. (NASDAQ: MRNA) Q3 2020 earnings call dated Oct. 29, 2020 Corporate Participants: Lavina Talukdar -- Senior Vice President & Head of Investor
Moderna reports higher earnings, wider loss in Q3
Moderna Inc (NASDAQ: MRNA) reported third-quarter 2020 financial results before the opening bell on Thursday. The frontrunner in COVID vaccine research reported
Infographic: Highlights of Merck & Co. (MRK) Q3 2020 earnings report
Merck & Co., Inc. (NYSE: MRK) reported stronger than expected earnings and sales for the third quarter of 2020. The company's stock